Greenwich LifeSciences (GLSI) Non-Current Assets (2019 - 2024)

Greenwich LifeSciences (GLSI) has 4 years of Non-Current Assets data on file, last reported at $1779.0 in Q4 2024.

• Quarterly Non-Current Assets changed N/A year-over-year to $1779.0 in Q4 2024, while the trailing twelve-month figure through Dec 2025 was $29718.0 (down 34.02% YoY) and the FY2024 annual result came in at $1779.0, changed N/A from the prior year.
• Non-Current Assets fell to $1779.0 in Q4 2024, from $13518.0 in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $17130.0 in Q3 2020 to a low of $1779.0 in Q4 2024.
• A 3-year average of $13066.5 and a median of $14872.5 in 2021 frame the typical range for Non-Current Assets.
• Annual changes were most pronounced in 2020 — Non-Current Assets decreased 18.19% — and 2021, when it declined 21.09%.
• Tracing GLSI's Non-Current Assets over 3 years: stood at $16227.0 in 2020, then dropped by 16.69% to $13518.0 in 2021, then tumbled by 86.84% to $1779.0 in 2024.
• The last three Non-Current Assets figures came in at $1779.0 (Q4 2024), $13518.0 (Q3 2021), and $14421.0 (Q2 2021), per Business Quant data.